A simple and effective approach for the treatment of diabetic foot ulcers with different Wagner grades.
Diabetic foot infections are the major cause of morbidity. Infection is the common sequel of diabetic foot ulceration that leads to delayed wound healing. These infections are difficult to control. If not addressed well in time, they may lead to amputation of foot. An attempt has been made to develop simple and effective treatment modality by using citric acid as a sole antimicrobial agent to control diabetic foot infections not responding to conventional treatment. Hundred and fifteen cases of diabetic foot ulcers of different Wagner grades infected with a variety of bacteria were investigated for culture and susceptibility, and susceptibility to citric acid. Citric acid gel was applied to ulcer to determine its efficacy in the management of diabetic foot ulcers with different Wagner grades. Citric acid gel was found effective in the control of foot infections; especially in Wagner grades I and II, the success rate was found to be more than 94%. In Wagner grade III also, it was found effective in complete healing of ulcers without deep osteomyelitis. Citric acid treatment is effective in the control of diabetic foot infections and in successful management of diabetic foot ulcers with Wagner grades I and II, and even with Wagner grade III, without deep osteomyelitis.
Nagoba
Basavraj S
BS
Department of Microbiology, MIMSR Medical College and YCR Hospital, Latur, India. dr_bsnagoba@yahoo.com
Gandhi
Rajan C
RC
Wadher
Bharat J
BJ
Rao
Arunkumar
A
Hartalkar
Amol R
AR
Selkar
Sohan P
SP
D000279:Administration, Cutaneous; D000328:Adult; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D019343:Citric Acid / Q000494:pharmacology / Q000627:therapeutic use*; D017719:Diabetic Foot / Q000150:complications*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005782:Gels; D006801:Humans; D017053:Infection Control / Q000379:methods; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy; D012189:Retrospective Studies; D012720:Severity of Illness Index; D017592:Skin Care / Q000379:methods; D013203:Staphylococcal Infections / Q000188:drug therapy; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects; D014946:Wound Infection / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
D005782:Gels; D019343:Citric Acid
Am J Clin Pathol. 1966 Apr;45(4):493-6
5325707
J Med Microbiol. 2008 May;57(Pt 5):681-682
18436609
Diabetologia. 1993 Feb;36(2):150-4
8458529
Acta Chir Scand Suppl. 1966;357:166-76
5335618
J Hosp Infect. 2008 Jun;69(2):177-80
18485531
J Surg Res. 1974 Apr;16(4):299-306
4208080
J Hosp Infect. 1998 Oct;40(2):155-7
9819695
Burns. 1998 Aug;24(5):481-3
9725693
Diabet Med. 1996;13 Suppl 1:S12-6
8741822
JAMA. 2005 Jan 12;293(2):217-28
15644549
Br J Dermatol. 2002 Jun;146(6):1101
12072088
Diabetes Care. 1990 May;13(5):513-21
2351029
J Vasc Nurs. 1999 Mar;17(1):17-23
10362983
Arch Surg. 1986 Feb;121(2):191-5
3511888
Acta Orthop Scand. 1995 Apr;66(2):181-92
7740955